Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,600.00
Bid: 1,598.00
Ask: 1,598.50
Change: -4.50 (-0.28%)
Spread: 0.50 (0.031%)
Open: 1,613.00
High: 1,613.00
Low: 1,589.00
Prev. Close: 1,604.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

Wed, 01st May 2024 16:56

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

The FTSE 100 index closed down 22.89 points, 0.3%, at 8,121.24. The FTSE 250 ended down 38.80 points, 0.2%, at 19,926.59, and the AIM All-Share closed up 4.24 points, 0.6%, at 764.98.

The Cboe UK 100 ended down 0.3% at 811.07, the Cboe UK 250 closed down 0.4% at 17,230.04, and the Cboe Small Companies ended up 0.2% at 15,762.48.

Financial markets in Paris and Frankfurt are closed on Wednesday.

The Fed announces its latest interest rate decision at 1900 BST. A press conference with Chair Jerome Powell follows half an hour later.

"It's decision day on interest rates in the US and while the Federal Reserve is almost certain to stick with the status quo, there will be considerable interest in the accompanying commentary. Will markets have to get used to the idea of zero cuts in 2024, having started the year with hopes for rates to be materially lowered?" said AJ Bell's Russ Mould.

Before the Fed decision, there has been a flurry of US data.

The US private sector added more jobs than expected last month, numbers from payroll firm ADP showed.

According to the latest ADP tracker, private employers added 192,000 jobs in April, rising from 184,000 in March. The March reading was downwardly revised from an initially reported 208,000. The latest reading beat the FXStreet cited consensus of 175,000.

The US manufacturing sector was stable in April, purchasing managers' index survey results from S&P Global confirmed on Wednesday, but data from the Institute for Supply Management showed the sector fell into contraction.

The S&P Global US manufacturing PMI posted in line with the 50.0 no-change mark in April to point to stable business conditions at the start of the second quarter. The reading was down from 51.9 in March and signalled an end to a three-month sequence of improving operating conditions.

The ISM PMI reported that economic activity in the manufacturing sector contracted in April after one month of expansion following 16 consecutive months of contraction.

The ISM PMI for manufacturing reading slipped to 49.2 points in April from 50.3 in March.

Stocks in New York were mixed at the London equities close. The DJIA was up 0.2%, though the S&P 500 index and Nasdaq Composite were down 0.4% and 0.5%, respectively.

The pound was quoted at USD1.2487 at the London equities close Wednesday, down compared to USD1.2523 at the close on Tuesday. The euro stood at USD1.0679 at the European equities close Wednesday, lower against USD1.0690 at the same time on Tuesday.

Against the yen, the dollar was trading at JPY157.72, up compared to JPY157.44 late Tuesday.

In the FTSE 100, Haleon lost 3.1%.

The Surrey, England-based consumer health arm, spun out of GSK PLC, backed its annual guidance and reported a "solid" quarter.

Revenue declined 2.2% on-year to GBP2.92 billion in the three months that ended March 31, as revenue for Haleon's Pain Relief and Respiratory Health units fell amid a weaker Covid season in China compared to a year ago.

Cost of sales were reduced by 5.7% to GBP1.08 billion from GBP1.15 billion, helping pretax profit to grow by 8.9% to GBP590 million from GBP542 million.

On the other hand, GSK rose 1.6%.

The London-based pharmaceutical maker said revenue in the first-quarter of the year was up 5.9% to GBP7.36 billion from GBP6.95 billion a year prior.

Pretax profit, however, weakened 29% to GBP1.36 billion from GBP1.91 billion.

In the FTSE 250, Aston Martin lost 6.8%, after a disappointing trading update.

The company reported 945 vehicle sales in the first quarter, down 26% from 1,269 a year before.

Pretax loss widened 87% to GBP138.8 million from GBP74.2 million.

Executive Chair Lawrence Stroll said: "2024 is a year of immense product transformation at Aston Martin, with the introduction of four new models to the market before the end of the year. Our first quarter performance reflects this expected period of transition, as we ceased production and delivery of our outgoing core models ahead of the ramp up in production of the new Vantage, upgraded DBX707 and our upcoming V12 flagship sports car which we've confirmed today. As part of our ongoing programme of ultra-exclusive models, we will deliver a new Special in the fourth quarter of the year."

On AIM, Trinity Exploration & Production rose 53%. Touchstone Exploration shares fell 4.5%.

Touchstone Exploration said it reached an agreement to buy Trinity Exploration & Production.

The Trinidad & Tobago-focused oil exploration and production companies aim to become "a leading Trinidadian operator of scale," according to Touchstone, which calls itself the largest independent onshore oil and natural gas producer in Trinidad.

The all-share agreement values Trinity at GBP24.1 million.

Brent oil was quoted at USD83.78 a barrel at the London equities close Wednesday, down from USD86.42 late Tuesday.

Gold was quoted at USD2,308.30 an ounce at the London equities close Wednesday, up against USD2,298.10 at the close on Tuesday.

In Thursday's UK corporate calendar, has first quarter results from Endeavour Mining, Shell, and Standard Chartered.

The economic calendar for Thursday has manufacturing PMIs from Germany and the eurozone. At 1330 BST, there is the weekly US initial jobless claims, as well as trade balance data.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
3 Jun 2024 17:19

Pharma, energy stocks drag London's FTSE 100; ECB rate cut hopes cap losses

FTSE 100 down 0.2%, FTSE 250 up 0.8%

*

Read more
3 Jun 2024 17:00

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York

(Alliance News) - The FTSE 100 in London closed lower on Monday, marking a mixed start to June, with GSK firmly at the bottom of the index.

Read more
3 Jun 2024 14:01

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.

Read more
3 Jun 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence

(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.

Read more
3 Jun 2024 09:08

TOP NEWS: GSK vows to appeal adverse Delaware court ruling on Zantac

(Alliance News) - GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning the heartburn drug, Zantac.

Read more
3 Jun 2024 08:37

LONDON MARKET OPEN: Stocks up amid slew of manufacturing PMIs

(Alliance News) - Stock prices in London opened higher on Monday, ahead of local purchasing managers index data, and comparative prints from several other major global economies.

Read more
3 Jun 2024 08:00

LONDON BRIEFING: FTSE 100 seen up; GSK defends ranitidine cancer claim

(Alliance News) - Stocks in London are set to open higher on Monday, ahead of a data-heavy week, kicked off by a slew of manufacturing purchasing managers' index readings.

Read more
3 Jun 2024 07:30

GSK to appeal Delaware ruling on jury trials in Zantac cancer cases

(Sharecast News) - GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.

Read more
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.